The first respondent, Leopont 64 Properties (Pty) Ltd, owned a farm and intended to develop a township known as Kosmos Extension 6 Township. During March-May 2004, Leopont concluded pre-proclamation sale agreements with various purchasers for erven (plots) in the proposed township, with consent from the Local Municipality of Madibeng under s 97(1) of the Town Planning and Township Ordinance 15 of 1986. The township was proclaimed on 31 May 2005, subdivision was authorised in October 2005, and the General Plan was approved on 8 December 2005. Transfer of the erven to purchasers occurred on 16 August 2006. The purchasers subsequently ceded their rights to the appellant, Kosmos X6 Homeowners Association. The sale agreements included obligations for Leopont to construct various facilities within the township including security features, landscaping, parks, water troughs, parking areas, recreational facilities, sewerage infrastructure, and other amenities. On 3 May 2007, the appellant's attorneys demanded performance of outstanding obligations. Leopont's attorneys responded on 4 June 2007 listing outstanding services and works. On 18 August 2008, Kosmos issued summons seeking rectification of the agreements and specific performance of various obligations that Leopont allegedly failed to perform, alternatively damages. Leopont raised a special plea of prescription, arguing that the claims became due when the agreements were concluded in March-May 2004 and had therefore prescribed more than three years before service of the summons.
1. The appeal was upheld with costs, including the costs of two counsel. 2. The order of the trial court was set aside and replaced with: 'The special plea of prescription is dismissed with costs, including the costs of two counsel.' 3. The matter was referred back to the trial court for adjudication of all the appellant's claims, including whether Lombard and Partners' letter to Len Dekker and Associates, dated 4 June 2007, contains a binding undertaking to perform the obligations listed therein.
The binding legal principle established is that prescription under s 12(1) of the Prescription Act 68 of 1969 commences to run only when the debt is due, which occurs when there is a completed cause of action - when everything has happened that would entitle the creditor to institute action to obtain judgment. There is a crucial distinction between a debt arising (coming into existence) and a debt becoming due (being recoverable). In the context of pre-proclamation sale agreements for erven in a township, collateral obligations relating to facilities and services cannot become due before the main object of the agreement (creation and transfer of the erven) is capable of performance. Where a contract's principal obligation is to effect transfer of erven after proclamation of a township and registration of the erven, and there is neither an express time for performance nor an express condition upon which performance of ancillary obligations depends, such ancillary obligations relating to facilities can only become due (and prescription can only commence) from the date when the erven come into existence and the main object of the agreement becomes capable of performance. The court held that facilities intended to be enjoyed as accessories to erven cannot give rise to enforceable obligations independent of and prior to the existence of the erven themselves.
The court made several non-binding observations. First, it noted that the court a quo did not consider whether the letter from Leopont's attorney dated 4 June 2007 constituted an interruption of prescription, which the Supreme Court of Appeal stated it 'certainly would have been in respect of some of the obligations undertaken'. However, it was not necessary to decide this point given the court's conclusion on when prescription commenced. Second, the court observed that the plea of prescription could not apply to the claim for rectification of the agreements in this case, citing Boundary Financing Ltd v Protea Property Holdings (Pty) Ltd 2009 (3) SA 447 (SCA) para 13, though this point was not fully developed. Third, the court noted that although extensive evidence was led before the court a quo, the trial court decided the matter purely on the basis of prescription without making findings on other issues such as whether the agreements were invalid for contravention of s 67 of the Ordinance or whether Mr Grabe had authority to conclude the agreements. The court also observed that there was 'nothing to suggest that the terms of the authority were not met' regarding the Municipality's conditions. The court further noted that the trial court found no agreement had been concluded from the exchange of letters between attorneys but had not yet decided whether the letter from Leopont's attorneys contained a binding undertaking, which remained to be determined on remittal.
This judgment is significant in South African law for clarifying when prescription commences in cases involving sale agreements that are not immediately enforceable. It establishes important principles regarding the distinction between a debt arising and a debt becoming due for purposes of the Prescription Act 68 of 1969. The judgment is particularly relevant to property development and township establishment matters where pre-proclamation sale agreements are common. It protects purchasers in such transactions by recognizing that ancillary obligations cannot become due and prescription cannot commence to run until the main object of the agreement (transfer of the erven) can be performed. The case demonstrates the principle that prescription only commences when a creditor has a complete cause of action - that is, when all the necessary elements exist to enable the creditor to institute legal proceedings. The judgment reinforces that collateral or secondary obligations in a contract must be considered in the context of the main purpose of the agreement, and their enforceability is tied to the realization of that main purpose. This has broader implications for contracts where performance is dependent on future events or regulatory approvals.